Nelson Steven H 4
Research Summary
AI-generated summary
Health Catalyst (HCAT) Director Steven H. Nelson Receives RSU Award
What Happened
- Steven H. Nelson, a director of Health Catalyst, was granted 80,691 restricted stock units (RSUs) on 2026-07-16. The Form 4 reports the acquisition price as $0.00 because these RSUs are a compensatory award, not an open-market purchase or sale.
Key Details
- Transaction date: 2026-07-16; Form 4 filed: 2026-07-20 (timely per two-business-day rule).
- Amount granted: 80,691 RSUs; reported acquisition price: $0.00.
- Shares owned after transaction: not specified in the provided filing excerpt.
- Transaction code: A (award/grant).
- Footnote: RSUs granted under the Issuer’s 2019 Stock Option and Incentive Plan. Each RSU represents a contingent right to one share. Vesting occurs on the earlier of (i) one year after grant or (ii) the date of the next Annual Meeting of stockholders.
Context
- RSUs are a form of equity compensation; they convert to actual shares only upon vesting and typically trigger tax withholding when settled. This award reflects compensation to a director and is not the same as a purchase (which some investors view as a stronger bullish signal).